Cardio-Phoenix News & Updates
NT-proBNP and Diabetes: Risks of Misdiagnosis in Heart Failure
NT-proBNP and diabetes are closely linked, and this interplay can alter test interpretation in heart-failure diagnosis. N-terminal pro B-type natriuretic peptide (NT-proBNP) is a biomarker…
NT-proBNP in Heart Failure Diagnosis: Clinical Delay, Biomarker Limits, and the Need for Diagnostic Reinvention
Misconceptions, Misuse, and Missed Diagnoses in the Primary Care Pathway. Abstract – Misuse of NT-proBNP in Primary Care and Diagnostic Delays N-terminal pro B-type…
NT-proBNP in Heart Failure Diagnosis: Challenges, Clinical Effectiveness, and the Need for More Accurate Tools
Abstract N-terminal pro B-type natriuretic peptide (NT-proBNP) has long been used as a biomarker for diagnosing heart failure (HF), especially in emergency settings. However, its…
Cardio-Phoenix at the British Society for Heart Failure (BSH) 27th Annual Meeting
Dates: November 21–22, 2024, London, UK Our team at Cardio-Phoenix had the privilege of participating in the 27th Annual Meeting of the British Society for…
Cardio-Phoenix: Advancing Early Detection in First-Level Care at SEC 2024 Congress
Dates: October 24–26, 2024 | Bilbao, Spain Our team at Cardio-Phoenix was honored to participate in the Spanish Society of Cardiology (SEC) 2024 Congress on Cardiovascular Health,…
Exploring the Connection Between Diabetes and Cardiovascular Health at DPC 2024
Dates: October 15–16, 2024 | Olympia London, UK Cardio-Phoenix was honored to be invited to the Diabetes Professional Care conference in London. This integrated event…
Categories
- Announcement (22)
- Events (9)
- Insights (6)
- Publications (10)
- Use Case (8)
